PharmiWeb.com - Global Pharma News & Resources
17-Oct-2019

Programme Highlights Released for SMi’s 11th RNA Therapeutics Conference

SMi Reports: Featured presentations have been released for the 11th annual RNA Therapeutics pre-conference focus day and conference being held in London on the 18th – 20th January.
  
SMi Group are proud to announce the programme highlights for the RNA Therapeutics conference and focus day.  The event will bring together industry leaders to discuss news and knowledge and share solutions to overcome challenges in the field of RNA Therapeutics.

An early bird savings of £400 is available to those who register by 31st October.  Secure your place at http://www.therapeutics-rna.com/pharmiwebpr2    

Presenters at the conference will cover topics such as, the latest developments in oligonucleotide delivery systems, RNA delivery agents and RNA based therapeutics, in addition to, challenges for clinical translation of RNA-based therapeutics and the effects of future regulatory updates.  

Programme highlights include:

Day 1 Highlights:

Current progress of RNA therapeutics and industry overview: setting the scene

• Revisiting the essential concepts behind RNA therapy
• A brief history of RNA therapeutics and key technologies in the market considerations in formulation design and delivery
• Future outlook 

Shalini Andersson, Chief Scientist New Therapeutic Modalities, AstraZeneca 

Day 2 Highlights:

The upcoming regulatory updates in the EU clinical trials arena from a regulatory perspective

• Upcoming 2020 regulatory updates affecting EU clinical trials 
• Revisiting the regulatory environment and a prescription on how to interact with regulators
• Updates on regulatory expectations on reporting clinical trial data

Kirsty Wydenbach, Deputy Unit Manager, Clinical Trials Unit, MHRA

Focus Day Highlights:

Optimising Nanoparticle mediated delivery of siRNAs to treat cancer and fibrosis 

• Presenting a polypeptide nanoparticle mediated delivery system for siRNA therapeutics to treat cancer and fibrosis
• The benefits of the ability to deliver multiple siRNAs within the tumour microenvironment 
• Leveraging this capability to improve outcomes with Immune Checkpoint inhibitors

David Evans, CSO, Sirnaomics

Download the brochure and full programme from the event website at http://www.therapeutics-rna.com/pharmiwebpr2    

RNA Therapeutics
Conference:19th – 20th February 2020
Focus Day: 18th February 2020
London, UK

Proudly sponsored by:
ChemGenes | Thermo Fisher Scientific

--- ENDS – 
Contact Information:
For media enquiries contact Alia Malick on +44 (0)20 7827 6168 
For all delegate enquiries, contact Hakam Panum on +44 (0)20 7827 6128 
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk 

 

 

Editor Details

Related Links

Last Updated: 17-Oct-2019